Clinical Trial Update: Bioequivalence Study of Two Brivaracetam Oral Solutions in Healthy Adults Under Fasting and High-Fat Meal Conditions [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study evaluating two brivaracetam oral solutions in healthy adults under fasting and high-fat meal conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• BRIVARACETAM (brivaracetam)

Snippet

Sponsor: Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | Conditions: Epilepsy (treatment Refractory) | Phase 1 | Status: ENROLLING_BY_INVITATION